LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

4 months ago 11
Read Entire Article
  1. Homepage
  2. Finance
  3. LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Related

US retail sales beat expectations in August; weakening labor market dims outlook

US retail sales beat expectations in August; weakening labor...

9 minutes ago 0
AtriCure (ATRC) chief marketing officer sells $108,899 in stock

AtriCure (ATRC) chief marketing officer sells $108,899 in st...

9 minutes ago 0
Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints

Lantern Pharma stock climbs after LP-184 cancer drug hits tr...

9 minutes ago 0

Trending

1. brett goldstein
2. sydney mclaughlin-levrone
3. socialism
4. dustin hoffman
5. clint eastwood
6. delta airlines cancels flights
7. margot robbie
8. michael douglas
9. student loans
10. eric trump

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

7 months ago 553
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

6 months ago 267
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

8 months ago 252
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

6 months ago 217
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

6 months ago 209
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved